Skip to content
PICO Portalanswers from OpenAlex

Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy

PaperCitations, authors & open-access status

Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy have?

PICO Portalcitation count

Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy has 145 citations in the OpenAlex counts PICO Portal stores.

When was Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy published?

PICO Portalyear

Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy has 2011 year in the PICO Portal index.

What is the open-access status of Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?

PICO Portaloa status

Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy has closed oa status in the PICO Portal index.

What is the DOI of Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?

PICO Portaldoi

The DOI for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is on the source record.

What is the PMID of Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?

PICO Portalpmid

The PMID for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is on the source record.

What is the OpenAlex record for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?

PICO Portalopenalex

The OpenAlex for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial